FDA
-
-
-
-
-
-
-
Medicus Pharma secures $22 million structured financing facility
-
-
-
-
-
-
-
Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill
-
-
-
-
-
-
-
Medicus Pharma clarifies positive SkinJect phase 2 trial data
-
-
-
-
-
-
-
Medicus Pharma to discuss phase 2 results in investor fireside chat
-
-
-
-
-
-
-
Medicus Pharma reports phase 2 trial results for skin cancer treatment
-
-
-
-
-
-
-
Medicus Pharma amends LifeArc license, cuts Teverelix royalty to 2%
-
-
-
-
-
-
-
Medicus Pharma signs non-binding AI analytics deal with Reliant AI
-
325,726 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

